Millipore Sigma Vibrant Logo

129874 Amifostine - CAS 20537-88-6 - Calbiochem

A cell-permeable aminothiophosphate pro-drug that offers selective protection in many normal, but not in tumor, tissues against the toxic side-effects of radiation and cytotoxic drugs.

Amifostine - CAS 20537-88-6 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: 2-(3-Aminopropyl)aminoethyl phosphorothioate, trihydrate, S-2-(3-Aminopropylamino)ethyl-O,O-dihydrogen phosphorothioate, trihydrate

View Products on Sigmaaldrich.com
129874
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      20537-88-6C₅H₁₅N₂O₃PS •3H₂O
      Description
      Overview

      This product has been discontinued.



      A cell-permeable aminothiophosphate pro-drug that offers selective protection in many normal, but not in tumor, tissues against the toxic side-effects of radiation and cytotoxic drugs. Its cytoprotective activities have been attributed to its free radical scavenging properties of its active thiol metabolite, WR-1065. The critical step in its activation is its interaction with alkaline phosphatase that is differentially distributed in normal and neoplastic cells. A strong inducer of hypoxia-inducible factor-α1 (HIF-α1) and p53. Shown to reduce PARP proteolysis and levels of active caspase-3 in irradiated mouse ovaries.

      Catalogue Number129874
      Brand Family Calbiochem®
      Synonyms2-(3-Aminopropyl)aminoethyl phosphorothioate, trihydrate, S-2-(3-Aminopropylamino)ethyl-O,O-dihydrogen phosphorothioate, trihydrate
      References
      ReferencesDedieu, S., et al. 2010. BMC Medicine 8, 19.
      Yoon, Y.D., et al. 2005. In Vivo 19, 509.
      Koukourakis, M.I., et al. 2004. Cancer Chemother. Pharmacol. 53, 1.
      Blasiak, J., et al. 2002. Leukemia Res. 26, 1093.
      Product Information
      CAS number20537-88-6
      FormOff-white solid
      Hill FormulaC₅H₁₅N₂O₃PS •3H₂O
      Chemical formulaC₅H₁₅N₂O₃PS •3H₂O
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥99% by NMR
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 22

      Harmful if swallowed.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      129874 0

      Documentation

      Amifostine - CAS 20537-88-6 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Amifostine - CAS 20537-88-6 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      129874

      Références bibliographiques

      Aperçu de la référence bibliographique
      Dedieu, S., et al. 2010. BMC Medicine 8, 19.
      Yoon, Y.D., et al. 2005. In Vivo 19, 509.
      Koukourakis, M.I., et al. 2004. Cancer Chemother. Pharmacol. 53, 1.
      Blasiak, J., et al. 2002. Leukemia Res. 26, 1093.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision25-May-2012 JSW
      Synonyms2-(3-Aminopropyl)aminoethyl phosphorothioate, trihydrate, S-2-(3-Aminopropylamino)ethyl-O,O-dihydrogen phosphorothioate, trihydrate
      DescriptionA cell-permeable aminothiophosphate pro-drug that offers selective protection in many normal, but not in tumor, tissues against the toxic side-effects of radiation and cytotoxic drugs. Its cytoprotective activities have been attributed to its free radical scavenging properties of its active thiol metabolite, WR-1065. The critical step in its activation is its interaction with alkaline phosphatase that is differentially distributed in normal and neoplastic cells. A strong inducer of hypoxia-inducible factor-α1 (HIF-α1) and p53. Shown to reduce PARP proteolysis and levels of active caspase-3 in irradiated mouse ovaries.
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number20537-88-6
      Chemical formulaC₅H₁₅N₂O₃PS •3H₂O
      Structure formulaStructure formula
      Purity≥99% by NMR
      SolubilityH₂O
      Storage Protect from moisture
      Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      ReferencesDedieu, S., et al. 2010. BMC Medicine 8, 19.
      Yoon, Y.D., et al. 2005. In Vivo 19, 509.
      Koukourakis, M.I., et al. 2004. Cancer Chemother. Pharmacol. 53, 1.
      Blasiak, J., et al. 2002. Leukemia Res. 26, 1093.